Nigel P Murray

Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

Shelagh B. Coutts, Sandeep Ankolekar, Ramana Appireddy et al. · The Lancet · 2024 · 101 citations · Full text

Thrombosis, Superiority Trial, Ischemic Stroke +12

Redefining micrometastasis in prostate cancer - a comparison of circulating prostate cells, bone marrow disseminated tumor cells and micrometastasis: Implications in determining local or systemic treatment for biochemical failure after radical prostatectomy

Nigel P Murray, Eduardo Reyes, Pablo Tapía et al. · International Journal of Molecular Medicine · 2012 · 43 citations · Full text

Surgical Oncology, Biological Microenvironments, Blood Cell +21

Circulating Prostate Cells Found in Men with Benign Prostate Disease Are P504S Negative: Clinical Implications

Nigel P Murray, Eduardo Reyes, Leonardo Badínez et al. · Journal of Oncology · 2013 · 29 citations · Full text

Clinical Implications, Pathology, Tumor Biology +18

Differential Expression of Matrix Metalloproteinase-2 Expression in Disseminated Tumor Cells and Micrometastasis in Bone Marrow of Patients with Nonmetastatic and Metastatic Prostate Cancer: Theoretical Considerations and Clinical Implications—An Immunocytochemical Study

Nigel P Murray, Eduardo Reyes, Pablo Tapía et al. · Bone Marrow Research · 2012 · 28 citations · Full text

Mmp-2 Expression, Pathology, Tumor Cells +16

Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease

Nigel P Murray, Eduardo Reyes, Nelson Orellana et al. · The Scientific World JOURNAL · 2013 · 22 citations · Full text